Allogeneic cellular immune therapy (ACIT) system: Began Phase I testing

Cerus Corp. (CERS), Concord, Calif. Product: Allogeneic cellular immune therapy (ACIT) system Business: Transplant Therapeutic category: Cell proliferation Target: T cell DNA and RNA Description: S-59...